Intelligence / Healthtech / New Clinical Trials / Nivi, Inc.
Clinicaltrial registered20 Oct 2026
Nivi, Inc.
20 Oct 2026: Trial registered · Comparing AI and Standard Pregnancy Chatbots. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 20 Oct 2026
- Title
- Comparing AI and Standard Pregnancy Chatbots
- Conditions
- Pregnancy, Prenatal Care, Maternal Health
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Countries
- India
- Country
- India
- Reference
- NCT07883993
- Location
- India
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Nivi, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from India
New Clinical Trials
18 NovAstraZenecatrial registered · A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With HyperkalaemiaClinical12 NovNovo Nordisk A/Strial registered · A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothClinical6 NovAstraZenecatrial registered · A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesClinical28 OctEli Lilly and Companytrial registered · A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskClinical23 OctSichuan Credit Pharmaceutical Co., Ltd.trial registered · A Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent StudyClinical21 OctWockhardttrial registered · Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.